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The objective of this project is to generate a library of monoclonal antibodies (MAbs)
to surface molecules of mammahan tumor and transformed cells grown as
multicell spheroids (MCS). These MCS are highly organized, 3-dimensional
multicellular structures which exhibit many characteristics of in vivo organized
tissues not found in conventional monolayer or suspension culture; therefore, MCS
make better in vitro model systems to study the interactions of mammalian cells.
Additionally, they provide a functional assay for surface adhesion molecules.
The aims for this reporting period were: (1) to continue generating a library of
hybridomas producing antibodies against surface molecules of human and rodent
tumor and transformed cells grown as MCS using a subtractive immunization
scheme; and (2) to begin to characterize the binding patterns of selected MAbs from
our library on panels of human and rodent cell lines by immunofluorescence
microscopy and flow cytometry. To this end, six additional hybridomas producing
antibody of interest were identified and added to the library during the reporting
period. In addition, five hybridomas which were previously reported were cloned
and subcloned to ensure that they were producing monospecific antibody. We also
began to characterize the binding patterns of selected MAbs on panels of normal,
tumor and transformed human and rodent cell lines (see Appendix for list).
Prehminary results of these studies have identified three distinct monoclonal
antibody types: (1) MAbs that bind specifically to human cell lines; (2) MAbs that
bind specifically to rodent cell lines; and (3) MAbs that bind to both human and
rodent cell lines. Moreover, in some cases there were differences in binding pattern
and binding intensity between tumor/transformed and normal cell lines. (These
data have been summarized and are presented in the Appendix). This observation
is of great interest since the differences may reflect molecules which may be
expressed differentially in tumor/transformed and normal cells. Moreover, these
molecules could be the ones responsible for the abnormal behavior (aggregation,
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compaction, 3-dimensional growth) exhibited by tumor and transformed cells.
The specific aims for the next six-month period are: (1) to continue to expand our
MAb library; (2) to continue to characterize the binding pattern and binding
intensity of selected MAbs on panels of human and rodent cell lines; and (3) to
initiate functional biological assays to determine whether MAbs can modulate the
cell-cell interactions (aggregation, compaction) of normal, tumor and transformed
cells.
This project also supports the research training of two underrepresented minority
students (one graduate and one undergraduate). Both students made significant
contributions to the work accomplished during the reporting period. Moreover,
each student submitted an abstract and presented a paper at a national scientific
meeting (copy included in Appendix ). One student was accepted to the University
of Texas Medical School at Houston and will start in fall 1994.

Appendix

Tissue Culture Cell Lines
WI38sv40
WI38
Hela 6TG r-
IMR90sv40
IMR90
GM3320
Hep3b
2DF*F 1
B14150
CHO 77256
FTO-2B
Mouse L
human sv40 transformed lung fibroblast
normal human lung fibroblast
human cervical carcinoma (6TG resistant)
human sv40 transformed lung fibroblast
normal human lung fibroblast
human neuroblastoma
human hepatoma
Con A resistant mutant (of B14150)
Chinese hamster peritoneal
Chinese hamster ovary
rat liver cells: TK-
mouse fibroblast

Summary of monoclonal antibody 5A12 (WSJ-2) by fluorescence
microscopy.
CELL LINE FLUORESCENCE INTENSITY
FIXED LIVE
WI38sv40 _ +++
Hela 6TG r- +t- +++
IMR90sv40 4+ I.P.
GM3320 -H- I.P.
Hep3b _ I.P.
B14150 + I.P.
2DF*F1 + +
P_AZT.F..R_
cell-cell
cell-surface
cell-surface with cell-
cell
cytoplasmic
around edges & cell
surface
granular cytoplasmic
weak "all over"
CHO 77256
FTO-2B
Mouse L
++ I.P.
+t+ I.P.
cytoplasmic
granular cytoplasmic
I.P. = in progress
FLUORESCENCE INTENSITY
- = no fluorescence
+ = weak
++ = medium
+++ = strong
+4++ = very strong

ANTIBODY $A12 : This antibody has been renamed WSJ-2
and is a Kappa IgG1 isotype which
exhibits a cell- cell binding pattern
on WI38sv40 cells.
CELL LINE
WI38sv40
WI38
Hela 6TGr
2DF*F1
B14150
FLOW CYTOMETRY
*Net Fluorescence
+t+ (333.27)
+_ (236.02)
+ (173.41)
*NET FLUORESCENCE
- =<50
+ => 100
4+ =>200
+++ =>300
++4+ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonal antibody 10D8 (WSJ-3) by fluorescence
microscopy.
CELL LINE FLUORESCENCE INTENSITY
FIXED L I V E
WI38sv40 +t+ +++
Hela 6TG r- _ +++
IMR90sv40 +¢+ I.P.
GM3320 -¢+ I.P.
Hep3b + I.P.
B14150
2DF*F1
CHO 77256
Hep3b
FTO-2B
Mouse L
+ I.P.
-14- +
+++ I.P.
+ I.P.
+ I.P.
PATTERN
cell-cell
intermittant
cell-surface with cell-
cell
cytoplasmic
around edges of cell
cell-surface, some cell-
cell
cell-surface & between
cells
cytoplasmic
around edges of cell
granular cytoplasmic
I.P. = in progress
+
-H-
.+-I-I-
++++ =
FLUORF__CENCE INTENSITY
= no fluorescence
= weak
= medium
= strong
very strong

ANTIBODY 10D8 ; This antibody has been renamed WSJ-3
and is a Kappa IgG1 isotype which
exhibits a cell- cell binding pattern
on WI38sv40 cells.
CELL LINE
WI38sv40
WI38
Hela 6TGr
2DF*F1
B14150
FLOW CYTOMETRY
*Net Fluorescence
+t+ (308.67)
-H- (210.45)
+ (166.44)
*NET FLUORESCENCE
- =<50
+ =>100
4+ =>200
=> 300
++++ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

.Summary of monoclonal antibody 8El0 (WSJ-4) by fluorescence
microscopy.
CELL LINE FLUORESENCE INTENSITY
FIXED L I V E
WI38sv40 +t+ +++
Hela 6TG r- -_+ +++
IMR90sv40 -t+ I.P.
GM3320 -t+ I.P.
Hep3b +t+ I.P.
B14150 + I.P.
2DF*F1 - -
CHO 77256 ++ I.P.
FTO-2B -t++ I.P.
Mouse L - -
PATTERN
cell-cell
cell surface
cell-surface with cell-
cell
cytoplasmic
around edges & cell
surface
granular cytoplasmic
cytoplasmic
granular cytoplasmic
I.P. = in progress
FLUORF_CENCE INTENSITY
- = no fluorescence
+ = weak
++ = medium
+++ = strong
= very strong

ANTIBODY 8E10 ; This antibody has been renamed WSJ-4 and is
a Kappa IgG1 isotype which exhibits a cell-cell
binding pattern on WI38sv40 cells.
CELL LINE
WI38sv40
WI38
Hela 6TGr
2DF*F1
B14150
FLOW CYTOMETRY
*Net Fluorescence
+++ (316.99)
_- (219.70)
+ (165.66)
*NET FLUORESCENCE
- =<50
+ => 100
-t+ => 200
-H-+ => 300
++-1+ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonal antibody 6A3 (WSJ-5) by fluorescence
microscopy.
CELL LINE FLUORESCENCE INTENSITY
FIXED LIVE PATTERN
WI38sv40 +++ +++
Hela 6TG r- 4+ +++
IMR90sv40 44+ I.P.
GM3320 _ I.P.
Hep3b - I.P.
B14150 - I.P.
2DF*F1 - -
CHO 77256 - I.P.
FTO-2B I.P.
Mouse L
cell-surface
cell-surface
cell-surface
granular cell-surface
cytoplasmic
granular cytoplasmic
I.P. = in progress
FLUORESCENCE INTENSITY
- = no fluorescence
+ = weak
++ = medium
= strong
++-t+ = very strong

ANTIBODY 6A3 : This antibody has been renamed WSJ-5 and is
a Kappa IgG1 isotype which exhibits a cell-
surface binding pattern on WI38sv40 cells.
CELL LINE
WI38sv40
WI38
Hela 6TGr
2DF*F1
B14150
FLOW CYTOMETRY
*Net Fluorescencg
(367.87)
.t++ (390.22)
++++ (401.68)
*NET FLUORESCEN(_
=<50
+ => 100
=>200
=>300
++_ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonal antibody 3C3 (WSJ-6) by fluorescence
microscopy.
CELL LINE FLUORESCENCE INTENSITY
WI38sv40
Hela 6TG r-
IMR90sv40
GM3320
Hep3b
B14150
2Dr*F1
CHO 77256
FTO-2B
Mouse L
FIXED
44+
+t-
-t-,t-t+
L I V E PATTERN
+++ cell-surface
+++ cell-surface
I.P. cell-surface
I.P.
I.P.
I.P.
I.P. = in progress
FLUORF_CENCE INTENSITY
= no fluorescence
+ -- weak
++ = medium
+++ = strong
++++ = very strong

ANTIBODY 3C3 ; This antibody has been renamed WSJ-6 and is
a Kappa IgG1 isotype which exhibits a cell-
surface binding pattern on WI38sv40 cells.
CELL LINE
WI38sv40
WI38
Hela 6TGr
2DF*F1
B14150
FLOW CYTOMETRy
*Net Fluorescence
(413.83)
++_ (423.81)
++++ (452.11)
*NET FLUORF__CENCE
- =<50
+ => 100
=> 200
+++ =>300
+t-t-I- =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonjll antibody DF1.2 (BDFI.2) by fluorescence
microscopy.
CELL LINE
B14150
FLUORESCENCE
FIXED LIVE
+-IF
2DF*F1 +H- +++
CHO 77256 +++ I.P.
FTO-2B + I.P.
WI38sv40 + I.P
Hela 6TG r- I.P.
IMR90sv40 - I.P.
GM3320 +/- I.P.
INTENSITY
PATTERN
cell-surface & cell-
cell
cell-surface & between
cells
cell-surface;some cell
to cell
weak cell surface
weak cell surface
n/a
n/a
binds only a
subpopulation of cells;
between cells
I.P. = in progress
+
+/-
-1-+
4-t+
4-+4-+ =
FLUORESCENCE INTENSITY
= no fluorescence
= weak
= subpop
= medium
= strong
very strong

ANTI.BODY DF1,2 ; This antibody has been renamed BDF1.2
and is a Kappa IgG1 isotype which
exhibits a cell- cell binding pattern
on 2DF*F1 and B14150 cells.
CELL LINE FLOW CYTOMETRY
*Net Fluorescence
2DF*FI ++++ (524.30)
B14150 ++++ (515.35)
WI38sv40 - (-6.6)
Hela 6TGr - (- 3.65 )
*NET FLUORESCENCE
=<50
+ =>50
-I+ =>200
+++ => 300
+'H'+ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonal antibody DF4.2 (BDF4.2) by fluorescence
microscopy.
CELL LINE
B14150
2DF*F1
CHO 77256
FLUORESCENCE
FIXED LIVE
INTENSITY
P_&Z.T.KI 
- n/a
+++ speckled/cell-cell
I.P. cell-surface;some cell
to cell
I.P. n/a
I.P n/a
I.P. n/a
I.P. n/a
I.P. n/a
-H-l-
+4-+
FTO-2B
WI38sv40
Hela 6TG r-
IMR90sv40
GM3320
I.P. = in progress
FLUORESCENCE INTENSITY
- = no fluorescence
+ = weak
+/- = subpop
++ = medium
+++ = strong
++++ = very strong

ANTIBODY DF4,2 ; This antibody has been renamed BDF4.2
and is a Kappa IgG1 isotype which
exhibits a fragmented (speckled)
binding pattern including localization to
intercellular boundaries and
extracellular matrix.
CELL LINE
2DF*F1
B14150
WI38sv40
Hela 6TGr
FLOW CYTOMETRY
*Net Fluorescence
+ (185.8)
- (2.85)
- (-6.6)
- (-3.65)
*NET FLUORESCENCE
- =< 50
+ =>50
4+ => 200
+++ =>300
-t-t-t+ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonal antibody 10HI0 (BDF7.1) by fluorescence
microscopy.
CELL LINE
B14150
FLUORESCENCE INTENSITY
FIXED LIVE
+ or- +/- cell surface; some cell-
cell
+++ +++ speckled/cell-cell
+++ I.P. speckled/cell-cell
- I.P. n/a
- I.P n/a
- I.P. n/a
- I.P. n/a
+/- I.P. n/a
2DF*F1
CHO 77256
FTO-2B
WI38sv40
Hela 6TG r-
IMR90sv40
GM3320
I.P. = in progress
FLUORESCENCEINTENSITY
= no fluorescence
+ = weak
+/- = subpop
++ = medium
+++ = strong
++++ = very strong
+ or - = unstable

ANTIBODY DF10H10 ; This antibody has been re,named BDF7.1
and is a Kappa IgG1 isotype which
exhibits a fragmented (speckled)
binding pattern including localization to
intercellular boundaries and
extracellular matrix.
CELL LINE
2DF*F1
B14150
WI38sv40
Hela 6TGr
FLOW CYTOMETRY
*Net Fluorescence
(10.05)
(10.0)
+ (159.15)
+ (71.75)
*NET FLUORESCENCE
- =<50
+ =>50
+1- => 200
=>300
++++ =>400
*Net fluorescence values were obtained by subtracting the mean
fluorescence value of the negative control, from the mean fluorescence
value of the monoclonal antibody being tested. (Mean fluorescence values
wer convertd from log to linear prior to calculations (logl0 X 256) ).

Summary of monoclonal antibody DF3.2 (B_.2) by fluorescence
microscopy.
CELL LINE FLUORESCENCE INTENSITY
FIXED LIVE
B14150 n/a
2DF*F1 +_ +++ speckled/cell-cell
CHO 77256 +++ I.P. speckled/cell-cell
FTO-2B + I.P. cell surface
WI38sv40 + I.P cell surface
Hela 6TG r- + I.P. cell surface
IMR90sv40 + I.P. cell surface
GM3320 + I.P. cell surface
I.P. = in progress
FLUORESCENCE INTENSITY
- = no fluorescence
+ = weak
+/- = subpop
++ = medium
= strong
++++ = very strong

Summary of monoclonal antil_ody 2Gll (BDF5.1) by fluorescence
microscopy.
CELL LINE FLUORESQENCE INTENSITY
FIXED LIVE
B14150
2DF*F1 ++++ ++++
CHO 77256 +++ I.P.
FTO-2B + I.P.
WI38sv40 - I.P
Hela 6TG r- - I.P.
IMR90sv40 - I.P.
GM3320 - I.P.
n/a
speckled/cell-cell
speckled/cell surface
cell surface
n/a
n/a
n/a
n/a
I.P. = in progress
FLUORESCENCE INTENSITY
- = no fluorescence
+ = weak
+/- = subpop
++ = medium
+++ = strong
++++ = very strong

Summary of monoclonal antibody 9C6 (BDF6.1) by fluorescence
microscopy.
CELL LINE FLUORESCENCE INTENSITy
FIXED LIVE P.A.T.ZER_
B14150 - - n/a
2DF*FI _ +++ speckled/cell-cell
CHO 77256 +++ I.P. speckled/cell surface
FTO-2B + I.P. cell surface
WI38sv40 I.P n/a
Hela 6TG r- I.P. n / a
IMR90sv40 - I.P. n/a
GM3320 - I.P. n / a
I.P. = in progress
FLUORESCENCE INTENSITY
- = no fluorescence
+ = weak
+/- = subpop
++ = medium
= strong
++++ = very strong
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ISOLATION OF MONOCLONAL ANTIBODIES TO SURFACE MOLECULES OF A
COMPACTION MUTANT OF THE MULTICELL SPHEROID PHENOTYPE
We are using multicell spheroids (MCS) to study cell-cell
interactions of transformed cells. MCS are formed via cellular processes
(i.e., aggregation and compaction) mediated by surface molecules. We have
produced several mutants of B14150 (hamster) cells which are defective
in MCS formation. In this study, we have used a subtractive immunization
technique to isolate monoclonal antibodies (MAbs) to surface molecules of
a compaction-defective mutant, ConAR-2DF-FI. Initial screening by
fluorescence microscopy revealed two major types of MAb-surface binding
patterns. One type of MAb preferentially localized to intercellular
boundaries, while a second type exhibited a more general staining pattern
including localization to intercellular boundaries and extracellular matrix.
Studies are now in progress to determine whether these MAbs block MCS
formation of wildtype B14150 cells. (Supported by NSF (RII-9005546),
NASA (NAG 2-819) and NIH (GM 08194) grants).
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C MONOCLONAL ANTIBODIES TO MULTICELL
SPHEROIDS OF HUMAN TRANSFORMED
CELLS USING A SUBTRACTIVE
IMMUNIZATION TECHNIQUE. CG Cantu, LA
Jordan, LS Armstrong, At Martinez, "llle University
of Texas at San Antonio, Division of Life Sciences,
San Antonio, "IX 78230.
Multicell tumor spheroids (MTS) are three-
dimensional in vitro models used in our laboratory
to study cellular and molecular mechanisms involved
in cell-cell interactions. MTS are formed via a two-
step process involving aggregation and compaction
mediated by surface molecules of tumor and
transformed cells. In this study, we are using a
subtractive immunization technique to increase
specificity to surface molecules involved in cell-cell
interactions. This scheme involved multiple
injections of WI38SV40 single cells (tolerogen) each
followed by injection of the immunosuppression
drug cyclophosphamide. Multiple injections of
WI38SV40 spheroids (immunogen) were then given,
theoretically generating antibodies that recognize the
molecules present on the immunogen that are not
present on the tolerogen. TIffs technique lms allowed
us to isolate an increased number of MAbs that
exhibit binding patterns at points of cell-cell contact
by florescence microscopy. The MAbs will be
further characterized by functional assays and flow
cytometry. Future studies will utilize the MAbs to
identify surface adhesion molecules involved in
MTS formation by Western blot analysis. (Supported
by NIH (GM 08194), and NASA (NAG 2-819)
grants, The University of Texas at San Antonio)
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